New Pharmacological Strategies for the Treatment of Atrial Fibrillation
Key result
Investigational pharmacological strategies for atrial fibrillation include atrial-specific ion channel inhibitors, upstream therapies, improved derivatives of older drugs, and gap junction therapy.
Population
Patients with atrial fibrillation
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Investigational AF agents should not yet change practice; leaves open multiple mechanistic pathways for targeted trials.
Structured PICO
P
Population
Patients with atrial fibrillation
I
Intervention
New pharmacological strategies including atrial-specific inhibitors (I(Kur), I(K-ACh), I(Na)), upstream therapies, derivatives of old anti-AF drugs, and gap junction therapy
Emerging pharmacological therapies for atrial fibrillation aim to improve efficacy and safety by targeting atrial-specific mechanisms and structural remodeling.
Cite This Study
Burashnikov et al. (2009) conducted a review in Atrial fibrillation. New pharmacological approaches was evaluated. Investigational pharmacological strategies for atrial fibrillation include atrial-specific ion channel inhibitors, upstream therapies, improved derivatives of older drugs, and gap junction therapy.